Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Afatinib

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    ECOGTHOS1403

    04/26/2016

    A Randomized Phase II/III Trial of Afatinib Plus Cetuximab Versus Afatinib Alone in Treatment-Naive Patients with Advanced, EGFR Mutation Positive Non-Small Cell Lung Cancer (NSCLC) (BI 1200.124)

    Treatment

    ECOGEAY131-M

    07/16/2015

    Molecular Analysis for Therapy Choice


    Print this page for your doctor